John  Sakys net worth and biography

John Sakys Biography and Net Worth

John V. Sakys joined us in October 2012 as our Chief Financial Officer.  From 2009 through October 2012, Mr. Sakys held several positions with The Berry Company, LLC, and its predecessor company, Local Insight Regatta Holdings, Inc., most recently as its Vice President and Chief Accounting Officer.  From 2001 to 2009, Mr. Sakys was the Vice President and Chief Financial Officer of Isonics Corporation, a NASDAQ listed company based in the Denver area.  From September 2000 to April 2001, Mr. Sakys was the Controller of AuraServ Communications.  From July 1998 to September 2000, Mr. Sakys was Director of Financial Reporting for Media One, Inc.  From December 1994 to July 1998, Mr. Sakys was an audit manager at Ernst and Young LLP.  Mr. Sakys received his Bachelor’s degree in Business Economics with an emphasis in accounting from the University of California at Santa Barbara and is a Certified Public Accountant.

What is John Sakys' net worth?

The estimated net worth of John Sakys is at least $1.06 million as of March 22nd, 2023. Mr. Sakys owns 9,696 shares of Mesa Laboratories stock worth more than $1,063,942 as of March 29th. This net worth approximation does not reflect any other assets that Mr. Sakys may own. Additionally, Mr. Sakys receives an annual salary of $551,400.00 as CFO at Mesa Laboratories. Learn More about John Sakys' net worth.

How old is John Sakys?

Mr. Sakys is currently 55 years old. There are 2 older executives and no younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who is 56 years old. Learn More on John Sakys' age.

What is John Sakys' salary?

As the CFO of Mesa Laboratories, Inc., Mr. Sakys earns $551,400.00 per year. The highest earning executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who commands a salary of $1,020,000.00 per year. Learn More on John Sakys' salary.

How do I contact John Sakys?

The corporate mailing address for Mr. Sakys and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on John Sakys' contact information.

Has John Sakys been buying or selling shares of Mesa Laboratories?

John Sakys has not been actively trading shares of Mesa Laboratories within the last three months. Most recently, John Sakys sold 2,128 shares of the business's stock in a transaction on Friday, March 24th. The shares were sold at an average price of $167.01, for a transaction totalling $355,397.28. Following the completion of the sale, the chief financial officer now directly owns 9,696 shares of the company's stock, valued at $1,619,328.96. Learn More on John Sakys' trading history.

Who are Mesa Laboratories' active insiders?

Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.

Are insiders buying or selling shares of Mesa Laboratories?

During the last twelve months, insiders at the medical instruments supplier sold shares 4 times. They sold a total of 7,500 shares worth more than $947,880.00. The most recent insider tranaction occured on December, 15th when SVP Brian David Archbold sold 1,500 shares worth more than $168,540.00. Insiders at Mesa Laboratories own 5.2% of the company. Learn More about insider trades at Mesa Laboratories.

Information on this page was last updated on 12/15/2023.

John Sakys Insider Trading History at Mesa Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/24/2023Sell2,128$167.01$355,397.289,696View SEC Filing Icon  
3/22/2023Sell2,500$171.62$429,050.009,696View SEC Filing Icon  
3/15/2023Sell1,000$165.71$165,710.009,696View SEC Filing Icon  
3/9/2023Sell400$169.97$67,988.009,696View SEC Filing Icon  
2/9/2023Sell1,000$184.27$184,270.009,696View SEC Filing Icon  
1/23/2023Sell2,100$210.19$441,399.009,696View SEC Filing Icon  
6/21/2022Sell722$188.22$135,894.848,678View SEC Filing Icon  
4/20/2022Sell72$250.44$18,031.687,514View SEC Filing Icon  
3/23/2022Sell930$251.29$233,699.70View SEC Filing Icon  
12/10/2021Sell1,758$324.74$570,892.92View SEC Filing Icon  
11/11/2021Sell1,000$317.12$317,120.00View SEC Filing Icon  
10/20/2021Sell2,000$309.86$619,720.00View SEC Filing Icon  
9/10/2021Sell1,400$270.21$378,294.008,914View SEC Filing Icon  
8/12/2021Sell1,000$275.16$275,160.008,514View SEC Filing Icon  
7/12/2021Sell1,000$278.77$278,770.008,514View SEC Filing Icon  
7/12/2021Sell1,000$278.77$278,770.00View SEC Filing Icon  
6/16/2021Sell2,119$255.67$541,764.739,633View SEC Filing Icon  
3/12/2021Sell2,500$263.84$659,600.004,850View SEC Filing Icon  
1/6/2021Sell16$290.00$4,640.003,366View SEC Filing Icon  
11/17/2020Sell984$290.00$285,360.004,334View SEC Filing Icon  
10/8/2020Sell942$276.90$260,839.804,292View SEC Filing Icon  
9/1/2020Sell298$250.00$74,500.003,698View SEC Filing Icon  
8/14/2020Sell1,000$244.00$244,000.004,500View SEC Filing Icon  
8/15/2018Sell1,000$203.50$203,500.003,500View SEC Filing Icon  
11/17/2016Sell1,000$127.14$127,140.002,000View SEC Filing Icon  
See Full Table

John Sakys Buying and Selling Activity at Mesa Laboratories

This chart shows John Sakys's buying and selling at Mesa Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mesa Laboratories Company Overview

Mesa Laboratories logo
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $109.73
Low: $107.11
High: $111.29

50 Day Range

MA: $101.41
Low: $90.62
High: $114.10

2 Week Range

Now: $109.73
Low: $82.86
High: $187.75

Volume

43,175 shs

Average Volume

37,478 shs

Market Capitalization

$591.44 million

P/E Ratio

645.51

Dividend Yield

0.60%

Beta

0.83